When delivered to mice with glioma tumors, the SR-717 accumulated in the TME, leading to an immune response characterized by increased expression of STING signaling-related proteins, higher levels of proinflammatory cytokines, and increased recruitment of immune cells into the tumor tissue. The gene discussed is STING1; the disease is neoplasm.